---

Market Overview

---

The global medical device coatings market is projected to reach USD 15.2 billion by 2027, growing at a CAGR of 6.9% from 2021 to 2027.

The market growth is primarily driven by the increasing demand for minimally invasive surgeries and the development of innovative coating materials. With a high prevalence of hospital-acquired infections (HAIs), there is a rising need to coat medical devices. Antimicrobial coatings, including nano coatings, have emerged as effective solutions against HAIs due to their long-lasting properties, cost-effectiveness, and ability to inhibit bacterial growth.

The COVID-19 pandemic has significantly shifted the focus towards hygiene and cleanliness, thereby generating greater interest in medical device coatings. The surge in COVID-19 cases, coupled with the demand for safer medical procedures and the expansion of healthcare infrastructure, has further intensified the requirement for medical device coatings.

Hospitals, diagnostic centers, ambulatory surgical centers, medical institutes, and research laboratories are the primary end-users driving the growth of the medical device coatings industry.

Many original equipment manufacturers (OEMs) are outsourcing their medical devices for coatings, which proves advantageous for manufacturers. However, the market growth may face challenges due to fluctuating materials prices, concerns regarding the biocompatibility of coatings, and stringent regulatory guidelines.

Advancements in coating techniques, such as laser treatments, low-temperature atmospheric plasmas, and micro blasting, are creating new opportunities for vendors in the market. Additionally, there has been a notable increase in start-up organizations offering coatings for medical devices. These start-ups provide state-of-the-art materials for a wide range of medical devices across various critical applications.

Medical device engineers are continually seeking ways to enhance the performance of medical device substrates through engineered coatings. Furthermore, the growing demand for antimicrobial coatings in the healthcare sector represents an emerging trend driven by the increasing target population affected by HAIs.

---

Market Segmentation

---

The market is segmented based on various factors, including coating type, material, product, and geography.

Segmentation by Coating Type
Hydrophilic
Antimicrobial
Drug-eluting
Thromboresistant
Others

Segmentation by Material
Metallic
Non-metallic

Segmentation of Product
Catheters
Implants
Electrosurgical Instruments
Stents
Other

Segmentation by Geography
North America – US, Canada
Europe – Germany, France, UK, Italy, Spain
APAC – China, Japan, India, South Korea, Australia
Latin America – Brazil, Mexico, Argentina
Middle East & Africa – South Africa, Saudi Arabia, Turkey

During the forecast period, the hydrophilic segment is projected to witness the highest incremental growth. This can be attributed to the increasing demand for biocompatible and durable hydrophilic coatings in the fields of cardiology and urology. Healthcare organizations’ emergency departments and labor & delivery units are utilizing hydrophilic coated devices due to their disposable capacity.

Meanwhile, the antimicrobial coating devices market is expected to experience the highest absolute growth rate of 51.09% during the forecast period. Metallic coatings offer various advantages such as long-lasting protection, cleanliness, cost-effectiveness, and fine finishing. They have found wide adaptation in vascular catheters, prosthetic heart valve sewing rings, fracture-fixation devices, and surgical sutures. Silver and copper, among other metals, have been extensively commercially deployed as antimicrobials.

The global catheter coatings market is anticipated to grow at an impressive CAGR of 6.48% during the forecast period. The industry growth will be further boosted by the widespread use of antibacterial coatings impregnated on catheters, such as rifampin, gentamicin, and vancomycin. Additionally, the demand for implantable medical devices (IMDs) is expected to increase significantly, especially for conditions associated with an aging population and the prevalence of chronic diseases.

In 2021, North America held a dominant portion of the global medical device coatings market share. The region’s growth is attributed to factors such as a rising geriatric population, increasing prevalence of infectious diseases, growing demand for minimally invasive procedures, and the need for high-quality healthcare equipment.

The APAC medical device coatings market is expected to grow at the fastest rate compared to other regions during the forecast period. This growth can be attributed to increasing healthcare expenditure, a rise in surgical procedures, and the development of medical infrastructure in the region.

---

Competitive Landscape

---

In the industry, the major players include AST Products, BioInteractions, Covalon, DSM, Hydromer, Specialty Coating Systems, and Sciessent. These leading companies are actively implementing various strategies such as product launches and approvals, marketing and promotional activities, acquisitions, increased investment in research and development, and strengthening their distribution networks. Their objective is to enhance their market share and presence.

Furthermore, these vendors are dedicated to expanding their market reach in both existing and new markets. This expansion aims to cater to the growing customer base, broaden their product portfolios, and improve their production capabilities. By doing so, they aim to garner increased attention and demand from end-users.

Key companies profiled in this report include Hydromer, Covalon, DSM, AST Products, BioInteractions, Specialty Coating Systems, Sciessent, Advanced Industrial Coatings, Allvivo Vascular, Avient, Axalta Coating Systems, BioCote, Biomerics, Carmeda AB, DOT GmbH, Endura Coatings, ENS Technology, Formacoat, Freudenberg Medical, Harland Medical Systems, Hemoteq addresses, Isoflux, jMedtech Coating Technologies, Merit Medical Systems, Microban, Mitsubishi Chemical America (AdvanSource Biomaterials), Mitsui Chemicals, NanoSono’s, Orchid, Orion Industries, Para-Coat Technologies, Precision Coating Company, Surmodics, The Sherwin-Williams Company, TST, TUA Systems, Wright Coating Technologies, Biocoat, Corline Biomedical, Surface Solutions Group, IST (Integrated Surface Technologies), Cytonix, Medtronic, Teleflex.

---

Key Questions Answered

---

What is the size of the medical device coatings market?

The global medical device coatings market is projected to reach a value of USD 15.2 billion by 2027, up from USD 10.6 billion in 2021.

How is the medical device coatings market expected to grow?

The medical device coatings market is anticipated to grow at a compound annual growth rate (CAGR) of 6.9% during the period of 2022 to 2027.

Which type of coatings for medical devices will remain highly preferred?

Hydrophilic coatings are expected to remain in high demand for medical devices.

Who are the major players in the global medical device coatings market?

The key players in the global medical device coatings market include AST Products, BioInteractions, Covalon, DSM, Hydromer, Specialty Coating Systems, and Sciessent.

What are the main trends that are driving the growth of the market?

The growth of the medical device coatings market is being driven by an increase in the demand for minimally invasive surgeries and advancements in technology.